Clinical Trial Update: Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of midodrine and atomoxetine for neurogenic orthostatic hypotension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Orthostatic Hypotension

Drugs mentioned

• Atomoxetine (Atomoxetine)
• Midodrine (Midodrine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Neurogenic Orthostatic Hypotension | Phase 4 | Status: COMPLETED